Vascular Calcification: An Important Understanding in Nephrology

References

• Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013;24(2):179–189. doi:10.1681/ASN.2011121191
   PubMed Web of Science ®Google Scholar
• Hénaut L, Chillon J-M, Kamel S, Massy ZA,. Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease. Semin Nephrol. 2018;38(3):233–250. doi:10.1016/j.semnephrol.2018.02.004
   PubMed Web of Science ®Google Scholar
• Voelkl J, Lang F, Eckardt KU, et al. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci. 2019;76(11):2077–2091. doi:10.1007/s00018-019-03054-z
   PubMed Web of Science ®Google Scholar
• Azpiazu D, Gonzalo S, Gonzalez-Parra E, Egido J, Villa-Bellosta R. Role of pyrophosphate in vascular calcification in chronic kidney disease. Nefrologia. 2018;38(3):250–257. doi:10.1016/j.nefro.2017.07.005
   PubMed Web of Science ®Google Scholar
• Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013;28(4):583–593. doi:10.1007/s00467-012-2347-x
   PubMed Web of Science ®Google Scholar
• Pérez-Hernández N, Aptilon-Duque G, Blachman-Braun R, et al. Vascular calcification: current genetics underlying this complex phenomenon. Chin Med J (Engl). 2017;130(9):1113–1121. doi:10.4103/0366-6999.204931
   PubMed Web of Science ®Google Scholar
• Bowman MAH, McNally EM. Genetic pathways of vascular calcification. Trends Cardiovasc Med. 2012;22(4):93–98. doi:10.1016/j.tcm.2012.07.002
   PubMed Web of Science ®Google Scholar
• Leopold JA. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015;25(4):267–274. doi:10.1016/j.tcm.2014.10.021
   PubMed Web of Science ®Google Scholar
• Zeper LW, de Baaij JHF. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop. Curr Opin Nephrol Hypertens. 2019;28(4):368–374. doi:10.1097/MNH.0000000000000509
   PubMed Web of Science ®Google Scholar
• Viegas CSB, Santos L, Macedo AL, et al. Chronic kidney disease circulating calciprotein particles and extracellular vesicles promote vascular calcification: a role for GRP (Gla-Rich Protein). Arterioscler Thromb Vasc Biol. 2018;38(3):575–587. doi:10.1161/ATVBAHA.117.310578
   PubMed Web of Science ®Google Scholar
• Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res. 2011;109(5):578–592. doi:10.1161/CIRCRESAHA.111.247965
   PubMed Web of Science ®Google Scholar
• Schurgers LJ, Barreto DV, Barreto FC, et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5(4):568–575. doi:10.2215/CJN.07081009
   PubMed Web of Science ®Google Scholar
• Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant. 2012;27(5):1957–1966. doi:10.1093/ndt/gfr609
   PubMed Web of Science ®Google Scholar
• Shroff RC, McNair R, Figg N, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118(17):1748–1757. doi:10.1161/CIRCULATIONAHA.108.783738
   PubMed Web of Science ®Google Scholar
• Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2017;100:87–93. doi:10.1016/j.bone.2016.11.012
   PubMed Web of Science ®Google Scholar
• Henaut L, Mary A, Chillon JM, Kamel S, Massy ZA. The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. Toxins (Basel). 2018;10(6):218. doi:10.3390/toxins10060218
   PubMed Web of Science ®Google Scholar
• Opdebeeck B, Maudsley S, Azmi A, et al. Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol. 2019;30(5):751–766. doi:10.1681/ASN.2018060609
   PubMed Web of Science ®Google Scholar
• Disthabanchong S. Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol. 2012;1(2):43–53. doi:10.5527/wjn.v1.i2.43
   PubMedGoogle Scholar
• Sanchis P, Ho CY, Liu Y, et al. Arterial “inflammaging” drives vascular calcification in children on dialysis. Kidney Int. 2019;95(4):958–972. doi:10.1016/j.kint.2018.12.014
   PubMed Web of Science ®Google Scholar
• Frauscher B, Kirsch AH, Schabhuttl C, et al. Autophagy protects from uremic vascular media calcification. Front Immunol. 2018;9:1866. doi:10.3389/fimmu.2018.01866
   PubMed Web of Science ®Google Scholar
• Lee K, Kim H, Jeong D. Microtubule stabilization attenuates vascular calcification through the inhibition of osteogenic signaling and matrix vesicle release. Biochem Biophys Res Commun. 2014;451(3):436–441. doi:10.1016/j.bbrc.2014.08.007
   PubMed Web of Science ®Google Scholar
• Ma WQ, Sun XJ, Wang Y, Zhu Y, Han XQ, Liu NF. Restoring mitochondrial biogenesis with metformin attenuates beta-GP-induced phenotypic transformation of VSMCs into an osteogenic phenotype via inhibition of PDK4/oxidative stress-mediated apoptosis. Mol Cell Endocrinol. 2019;479:39–53. doi:10.1016/j.mce.2018.08.012
   PubMed Web of Science ®Google Scholar
• Yao L, Wang J, Tian BY, Xu TH, Sheng ZT. Activation of the Nrf2-ARE signaling pathway prevents hyperphosphatemia-induced vascular calcification by inducing autophagy in renal vascular smooth muscle cells. J Cell Biochem. 2017;118(12):4708–4715. doi:10.1002/jcb.26137
   PubMed Web of Science ®Google Scholar
• Panda DK, Bai X, Sabbagh Y, et al. Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification. Am J Physiol Renal Physiol. 2018;314(6):F1046–f61. doi:10.1152/ajprenal.00350.2017
   PubMed Web of Science ®Google Scholar
• Lee K, Kim H, Jeong D. Protein kinase C regulates vascular calcification via cytoskeleton reorganization and osteogenic signaling. Biochem Biophys Res Commun. 2014;453(4):793–797. doi:10.1016/j.bbrc.2014.10.026
   PubMed Web of Science ®Google Scholar
• Hortells L, Sosa C, Guillen N, Lucea S, Millan A, Sorribas V. Identifying early pathogenic events during vascular calcification in uremic rats. Kidney Int. 2017;92(6):1384–1394. doi:10.1016/j.kint.2017.06.019
   PubMed Web of Science ®Google Scholar
• Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014;307(8):F891–F900. doi:10.1152/ajprenal.00163.2014
   PubMed Web of Science ®Google Scholar
• Lang F, Leibrock C, Pelzl L, et al. Therapeutic interference with vascular calcification-lessons from klotho-hypomorphic mice and beyond. Front Endocrinol (Lausanne). 2018;9:207. doi:10.3389/fendo.2018.00207
   PubMed Web of Science ®Google Scholar
• Kanno Y, Into T, Lowenstein CJ, Matsushita K. Nitric oxide regulates vascular calcification by interfering with TGF- signalling. Cardiovasc Res. 2008;77(1):221–230. doi:10.1093/cvr/cvm049
   PubMed Web of Science ®Google Scholar
• Cai T, Sun D, Duan Y, et al. WNT/beta-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 2016;345(2):206–217. doi:10.1016/j.yexcr.2016.06.007
   PubMed Web of Science ®Google Scholar
• Lee GL, Yeh CC, Wu JY, et al. TLR2 promotes vascular smooth muscle cell chondrogenic differentiation and consequent calcification via the concerted actions of osteoprotegerin suppression and IL-6-Mediated RANKL induction. Arterioscler Thromb Vasc Biol. 2019;39(3):432–445. doi:10.1161/ATVBAHA.118.311874
   PubMed Web of Science ®Google Scholar
• Osako MK, Nakagami H, Shimamura M, et al. Cross-talk of receptor activator of nuclear Factor-κB ligand signaling with renin–angiotensin system in vascular calcification. Arterioscler Thromb Vasc Biol. 2013;33(6):1287–1296. doi:10.1161/ATVBAHA.112.301099
   PubMed Web of Science ®Google Scholar
• Hamano T, Matsui I, Mikami S, et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol. 2010;21(11):1998–2007. doi:10.1681/ASN.2009090944
   PubMed Web of Science ®Google Scholar
• Aghagolzadeh P, Bachtler M, Bijarnia R, et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α. Atherosclerosis. 2016;251:404–414. doi:10.1016/j.atherosclerosis.2016.05.044
   PubMed Web of Science ®Google Scholar
• New SE, Aikawa E. Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification. Arterioscler Thromb Vasc Biol. 2013;33(8):1753–1758. doi:10.1161/ATVBAHA.112.300128
   PubMed Web of Science ®Google Scholar
• New SE, Goettsch C, Aikawa M, et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res. 2013;113(1):72–77. doi:10.1161/CIRCRESAHA.113.301036
   PubMed Web of Science ®Google Scholar
• Viegas C, Araujo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts. Aging (Albany NY). 2019;11(12):4274–4299. doi:10.18632/aging.102046
   PubMedGoogle Scholar
• Gauthier-Bastien A, Ung RV, Lariviere R, Mac-Way F, Lebel M, Agharazii M. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens. 2014;36(3):173–180. doi:10.3109/10641963.2013.804541
   PubMed Web of Science ®Google Scholar
• Pai AS, Giachelli CM. Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol. 2010;21(10):1637–1640. doi:10.1681/ASN.2010040349
   PubMed Web of Science ®Google Scholar
• Kapustin AN, Davies JD, Reynolds JL, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res. 2011;109(1):e1–e12. doi:10.1161/CIRCRESAHA.110.238808
   PubMed Web of Science ®Google Scholar
• Beazley KE, Nurminsky D, Lima F, Gandhi C, Nurminskaya MV. Wnt16 attenuates TGFbeta-induced chondrogenic transformation in vascular smooth muscle. Arterioscler Thromb Vasc Biol. 2015;35(3):573–579. doi:10.1161/ATVBAHA.114.304393
   PubMed Web of Science ®Google Scholar
• Chavkin NW, Chia JJ, Crouthamel MH, Giachelli CM. Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. Exp Cell Res. 2015;333(1):39–48. doi:10.1016/j.yexcr.2015.02.002
   PubMed Web of Science ®Google Scholar
• Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697–711. doi:10.1161/CIRCRESAHA.110.234914
   PubMed Web of Science ®Google Scholar
• Ciceri P, Galassi A, Alfieri C, Messa P, Cozzolino M. Uremic patients with increased vascular calcification score have serum with high calcific potential: role of vascular smooth muscle cell osteoblastic differentiation and apoptosis. Blood Purif. 2019;48(2):142–149. doi:10.1159/000497229
   PubMed Web of Science ®Google Scholar
• Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52(10):843–850. doi:10.1016/j.jacc.2008.05.043
   PubMed Web of Science ®Google Scholar
• Yamada S, Leaf EM, Chia JJ, Cox TC, Speer MY, Giachelli CM. PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet. Kidney Int. 2018;94(4):716–727. doi:10.1016/j.kint.2018.05.015
   PubMed Web of Science ®Google Scholar
• Zhang D, Bi X, Liu Y, et al. High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4/NF-kappab signaling pathway. Kidney Blood Press Res. 2017;42(6):1205–1215. doi:10.1159/000485874
   PubMed Web of Science ®Google Scholar
• Voelkl J, Luong TT, Tuffaha R, et al. SGK1 induces vascular smooth muscle cell calcification through NF-kappaB signaling. J Clin Invest. 2018;128(7):3024–3040. doi:10.1172/JCI96477
   PubMed Web of Science ®Google Scholar
• Belmokhtar K, Ortillon J, Jaisson S, et al. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression. Nephrol Dial Transplant. 2019;34(12):2018–2030. doi:10.1093/ndt/gfz012
   PubMed Web of Science ®Google Scholar
• Cianciolo G, Capelli I, Cappuccilli M, Schillaci R, Cozzolino M, La Manna G. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J. 2016;9(2):280–286. doi:10.1093/ckj/sfv145
   PubMed Web of Science ®Google Scholar
• Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S. Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation. 2012;125(22):2772–2781. doi:10.1161/CIRCULATIONAHA.112.090860
   PubMed Web of Science ®Google Scholar
• Soriano S, Carmona A, Trivino F, et al. Endothelial damage and vascular calcification in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2014;307(11):F1302–11. doi:10.1152/ajprenal.00114.2014
   PubMed Web of Science ®Google Scholar
• Shin V, Zebboudj AF, Bostrom K. Endothelial cells modulate osteogenesis in calcifying vascular cells. J Vasc Res. 2004;41(2):193–201. doi:10.1159/000077394
   PubMed Web of Science ®Google Scholar
• Cianciolo G, Capelli I, Cappuccilli M, et al. Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? Clin Kidney J. 2017;10(3):389–396. doi:10.1093/ckj/sfw145
   PubMed Web of Science ®Google Scholar
• Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res Ther. 2000;2(6):477–488. doi:10.1186/ar130
   Google Scholar
• Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun. 2007;354(2):453–458. doi:10.1016/j.bbrc.2006.12.226
   PubMed Web of Science ®Google Scholar
• Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow‐derived osteoblast progenitor cells are recruited to the bone‐forming site by the CXCR4/stromal cell‐derived factor‐1 pathway. Stem Cells. 2008;26(1):223–234. doi:10.1634/stemcells.2007-0515
   PubMed Web of Science ®Google Scholar
• Cianciolo G, La Manna G, Della Bella E, et al. Effect of vitamin D receptor activator therapy on vitamin D receptor and osteocalcin expression in circulating endothelial progenitor cells of hemodialysis patients. Blood Purif. 2013;35(1–3):187–195. doi:10.1159/000347102
   PubMed Web of Science ®Google Scholar
• Fadini GP, Albiero M, Menegazzo L, et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res. 2011;108(9):1112–1121. doi:10.1161/CIRCRESAHA.110.234088
   PubMed Web of Science ®Google Scholar
• Bardeesi ASA, Gao J, Zhang K, et al. A novel role of cellular interactions in vascular calcification. J Transl Med. 2017;15(1):95. doi:10.1186/s12967-017-1190-z
   PubMedGoogle Scholar
• El Agha E, Kramann R, Schneider RK, et al. Mesenchymal stem cells in fibrotic disease. Cell Stem Cell. 2017;21(2):166–177. doi:10.1016/j.stem.2017.07.011
   PubMed Web of Science ®Google Scholar
• Kramann R, Goettsch C, Wongboonsin J, et al. Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell. 2016;19(5):628–642. doi:10.1016/j.stem.2016.08.001
   PubMed Web of Science ®Google Scholar
• Jovanovich A, Isakova T, Stubbs J. Microbiome and Cardiovascular Disease in CKD. Clin J Am Soc Nephrol. 2018;13(10):1598–1604. doi:10.2215/CJN.12691117
   PubMed Web of Science ®Google Scholar
• Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Role of the Gut Microbiome in Uremia: a Potential Therapeutic Target. Am J Kidney Dis. 2016;67(3):483–498. doi:10.1053/j.ajkd.2015.09.027
   PubMed Web of Science ®Google Scholar
• Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, Zununi Vahed S. The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother. 2017;93:412–419. doi:10.1016/j.biopha.2017.06.066
   PubMed Web of Science ®Google Scholar
• Xu KY, Xia GH, Lu JQ, et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 2017;7(1):1445. doi:10.1038/s41598-017-01387-y
   PubMed Web of Science ®Google Scholar
• Stadlbauer V, Horvath A, Ribitsch W, et al. Author Correction: structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis. Sci Rep. 2019;9(1):8522. doi:10.1038/s41598-019-43263-x
   PubMedGoogle Scholar
• Nazzal L, Roberts J, Singh P, et al. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease. Nephrol Dial Transplant. 2017;32(11):1809–1817. doi:10.1093/ndt/gfx029
   PubMed Web of Science ®Google Scholar
• Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670. doi:10.1681/ASN.2013080905
   PubMed Web of Science ®Google Scholar
• Riccio E, Sabbatini M, Bruzzese D, et al. Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial. Clin Exp Nephrol. 2018;22(3):529–538. doi:10.1007/s10157-017-1504-8
   PubMed Web of Science ®Google Scholar
• Andersen K, Kesper MS, Marschner JA, et al. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol. 2017;28(1):76–83. doi:10.1681/ASN.2015111285
   PubMed Web of Science ®Google Scholar
• Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond). 2018;132(5):509–522. doi:10.1042/CS20171107
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4(10):1551–1558. doi:10.2215/CJN.03980609
   PubMed Web of Science ®Google Scholar
• Lin CJ, Liu HL, Pan CF, et al. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Arch Med Res. 2012;43(6):451–456. doi:10.1016/j.arcmed.2012.08.002
   PubMed Web of Science ®Google Scholar
• Asami M, Tanabe K, Ito S, et al. Impact of indoxyl sulfate on coronary plaques in patients on hemodialysis. Int Heart J. 2018;59(3):489–496. doi:10.1536/ihj.17-351
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Tsuruoka S, Ioka T, et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int. 2006;69(10):1780–1785. doi:10.1038/sj.ki.5000340
   PubMed Web of Science ®Google Scholar
• Yisireyili M, Saito S, Abudureyimu S, et al. Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS One. 2014;9(10):e109268. doi:10.1371/journal.pone.0109268
   PubMed Web of Science ®Google Scholar
• Azechi T, Sato F, Sudo R, Wachi H. 5-aza-2ʹ-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells. J Atheroscler Thromb. 2014;21(5):463–476. doi:10.5551/jat.20818
   PubMed Web of Science ®Google Scholar
• Xie SA, Zhang T, Wang J, et al. Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo: role of DNA methyltransferase 1. Biomaterials. 2018;155:203–216. doi:10.1016/j.biomaterials.2017.11.033
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang X, Zhang H, et al. Indoxyl sulfate enhance the hypermethylation of klotho and promote the process of vascular calcification in chronic kidney disease. Int J Biol Sci. 2016;12(10):1236–1246. doi:10.7150/ijbs.15195
   PubMed Web of Science ®Google Scholar
• Montes de Oca A, Madueno JA, Martinez-Moreno JM, et al. High-phosphate-induced calcification is related to SM22alpha promoter methylation in vascular smooth muscle cells. J Bone Miner Res. 2010;25(9):1996–2005. doi:10.1002/jbmr.93
   PubMed Web of Science ®Google Scholar
• Hou YC, Lu CL, Yuan TH, Liao MT, Chao CT, Lu KC. The epigenetic landscape of vascular calcification: an integrative perspective. Int J Mol Sci. 2020;21(3):980. doi:10.3390/ijms21030980
   PubMed Web of Science ®Google Scholar
• Fakhry M, Skafi N, Fayyad-Kazan M, et al. Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification. J Cell Physiol. 2018;233(5):4056–4067. doi:10.1002/jcp.26121
   PubMed Web of Science ®Google Scholar
• Massy ZA, Metzinger-le Meuth V, Metzinger L. MicroRNAs are associated with uremic toxicity, cardiovascular calcification, and disease. Contrib Nephrol. 2017;189:160–168.
   PubMed Web of Science ®Google Scholar
• Xu TH, Qiu XB, Sheng ZT, et al. Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and autophagy. J Cell Physiol. 2019;234(8):14306–14318. doi:10.1002/jcp.28130
   PubMed Web of Science ®Google Scholar
• Panizo S, Naves-Diaz M, Carrillo-Lopez N, et al. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus. J Am Soc Nephrol. 2016;27(3):824–834. doi:10.1681/ASN.2014050520
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J, Shen Z, et al. Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/beta-catenin signaling. Toxicol Lett. 2018;284:29–36. doi:10.1016/j.toxlet.2017.11.033
   PubMed Web of Science ®Google Scholar
• Wen P, Cao H, Fang L, et al. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res. 2014;322(2):302–312. doi:10.1016/j.yexcr.2014.01.025
   PubMed Web of Science ®Google Scholar
• Kétszeri M, Kirsch A, Frauscher B, et al. MicroRNA-142-3p improves vascular relaxation in uremia. Atherosclerosis. 2019;280:28–36. doi:10.1016/j.atherosclerosis.2018.11.024
   PubMed Web of Science ®Google Scholar
• Fourdinier O, Schepers E, Metzinger-Le Meuth V, et al. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients. Sci Rep. 2019;9(1):4477. doi:10.1038/s41598-019-41101-8
   PubMedGoogle Scholar
• Lee CT, Lee YT, Tain YL, Ng HY, Kuo WH. Circulating microRNAs and vascular calcification in hemodialysis patients. J Int Med Res. 2019;47(7):2929–2939. doi:10.1177/0300060519848949
   PubMed Web of Science ®Google Scholar
• Wang CL, Lin KP, Hsu GW, Liu KL, Guo CH. Altered mineral metabolism and disequilibrium between calcification promoters and inhibitors in chronic hemodialysis patients. Biol Trace Elem Res. 2019.
   Web of Science ®Google Scholar
• Akbari M, Nayeri H, Nasri H. Association of fetuin-A with kidney disease; a review on current concepts and new data. J Nephropharmacol. 2019;8(2).
   Google Scholar
• Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P. Early vascular ageing and cellular senescence in chronic kidney disease. Comput Struct Biotechnol J. 2019;17:721–729. doi:10.1016/j.csbj.2019.06.015
   PubMed Web of Science ®Google Scholar
• Maréchal C, Schlieper G, Nguyen P, et al. Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clin J Am Soc Nephrol. 2011;6(5):974–985. doi:10.2215/CJN.06150710
   PubMed Web of Science ®Google Scholar
• Koca N, Ersoy A, Şensoy B, et al. The association between cardiac valvular calcification and fetuin-A levels in kidney transplant recipients. Clin Exp Nephrol. 2019;23(10):1250–1256. doi:10.1007/s10157-019-01761-2
   PubMed Web of Science ®Google Scholar
• Price PA, Lim JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem. 2003;278(24):22144–22152. doi:10.1074/jbc.M300744200
   PubMed Web of Science ®Google Scholar
• Holt SG, Smith ER. Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. Nephrol Dial Transplant. 2016;31(10):1583–1587. doi:10.1093/ndt/gfw048
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Shanahan CM, de Baaij JHF. Magnesium counteracts vascular calcification: passive interference or active modulation? Arterioscler Thromb Vasc Biol. 2017;37(8):1431–1445. doi:10.1161/ATVBAHA.117.309182
   PubMed Web of Science ®Google Scholar
• Montezano AC, Zimmerman D, Yusuf H, et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension. 2010;56(3):453–462. doi:10.1161/HYPERTENSIONAHA.110.152058
   PubMed Web of Science ®Google Scholar
• Louvet L, Metzinger L, Buchel J, Steppan S, Massy ZA. Magnesium attenuates phosphate-induced deregulation of a microRNA signature and prevents modulation of Smad1 and osterix during the course of vascular calcification. Biomed Res Int. 2016;2016:7419524. doi:10.1155/2016/7419524
   PubMed Web of Science ®Google Scholar
• Montes de Oca A, Guerrero F, Martinez-Moreno JM, et al. Magnesium inhibits Wnt/beta-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One. 2014;9(2):e89525. doi:10.1371/journal.pone.0089525
   PubMed Web of Science ®Google Scholar
• Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol. 1987;65(4):729–745. doi:10.1139/y87-120
   PubMed Web of Science ®Google Scholar
• Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep. 2018;8(1):2069. doi:10.1038/s41598-018-20241-3
   PubMedGoogle Scholar
• Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond). 2012;123(7):399–416. doi:10.1042/CS20120074
   PubMed Web of Science ®Google Scholar
• Herencia C, Rodriguez-Ortiz ME, Munoz-Castaneda JR, et al. Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx. Eur J Clin Invest. 2015;45(11):1129–1144. doi:10.1111/eci.12517
   PubMed Web of Science ®Google Scholar
• de Borst MH, Vervloet MG. Ter Wee PM, Navis G. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol. 2011;22(9):1603–1609. doi:10.1681/ASN.2010121251
   PubMed Web of Science ®Google Scholar
• Goldfarb S, Martin K. Disorders of divalent ions, renal bone disease and nephrolithiasis. Nephrol Self Assess Program. 2018;17(3):205–209.
   Google Scholar
• Lu KC, Wu CC, Yen JF, Liu WC. Vascular calcification and renal bone disorders. Sci World J. 2014;2014:637065. doi:10.1155/2014/637065
   Google Scholar
• Kukida M, Mogi M, Kan-No H, et al. AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 2019;95(1):138–148. doi:10.1016/j.kint.2018.07.028
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou JJ, Robertson GR, Lee VW. Vitamin D in vascular calcification: a double-edged sword? Nutrients. 2018;10(5):652. doi:10.3390/nu10050652
   PubMed Web of Science ®Google Scholar
• Nitta K, Ogawa T, Hanafusa N, Tsuchiya K. Recent advances in the management of vascular calcification in patients with end-stage renal disease. Contrib Nephrol. 2019;198:62–72.
   PubMed Web of Science ®Google Scholar
• Schantl AE, Verhulst A, Neven E, et al. Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers. Nat Commun. 2020;11(1):721. doi:10.1038/s41467-019-14091-4
   PubMed Web of Science ®Google Scholar
• Schantl AE, Ivarsson ME, Leroux JCJAT. Investigational pharmacological treatments for vascular calcification. Adv Ther. 2019;2(1):1800094. doi:10.1002/adtp.201800094
   Google Scholar
• Chao CT, Yeh HY, Tsai YT, et al. Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification. Cell Death Discov. 2019;5:145. doi:10.1038/s41420-019-0225-z
   PubMed Web of Science ®Google Scholar
• Henze LA, Luong TTD, Boehme B, et al. Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Aging (Albany NY). 2019;11(15):5445–5462. doi:10.18632/aging.102130
   PubMedGoogle Scholar
• Chen B, Zhao Y, Han D, et al. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression. J Mol Cell Cardiol. 2019;135:10–21. doi:10.1016/j.yjmcc.2019.07.008
   PubMed Web of Science ®Google Scholar
• Wei R, Enaka M, Muragaki Y. Activation of KEAP1/NRF2/P62 signaling alleviates high phosphate-induced calcification of vascular smooth muscle cells by suppressing reactive oxygen species production. Sci Rep. 2019;9(1):10366. doi:10.1038/s41598-019-46824-2
   PubMedGoogle Scholar
• Li Z, Wu J, Zhang X, et al. CDC42 promotes vascular calcification in chronic kidney disease. J Pathol. 2019;249(4):461–471. doi:10.1002/path.5334
   PubMed Web of Science ®Google Scholar
• Paloian NJ, Leaf EM, Giachelli CM. Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. Kidney Int. 2016;89(5):1027–1036. doi:10.1016/j.kint.2015.12.046
   PubMed Web of Science ®Google Scholar
• Kuo TH, Lin WH, Chao JY, et al. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study. BMC Nephrol. 2019;20(1):266. doi:10.1186/s12882-019-1452-5
   PubMedGoogle Scholar
• Carracedo M, Witasp A, Qureshi AR, et al. Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease. J Intern Med. 2019;286(4):449–457. doi:10.1111/joim.12940
   PubMed Web of Science ®Google Scholar
• Hawkins CL. Protein carbamylation: a key driver of vascular calcification during chronic kidney disease. Kidney Int. 2018;94(1):12–14. doi:10.1016/j.kint.2018.03.022
   PubMed Web of Science ®Google Scholar
• Mori D, Matsui I, Shimomura A, et al. Protein carbamylation exacerbates vascular calcification. Kidney Int. 2018;94(1):72–90. doi:10.1016/j.kint.2018.01.033
   PubMed Web of Science ®Google Scholar
• Kaesler N, Goettsch C, Weis D, et al. Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant. 2019. doi:10.1093/ndt/gfy410
   PubMed Web of Science ®Google Scholar
• Nagy A, Petho D, Gall T, et al. Zinc Inhibits HIF-Prolyl hydroxylase inhibitor-aggravated VSMC calcification induced by high phosphate. Front Physiol. 2019;10:1584. doi:10.3389/fphys.2019.01584
   PubMed Web of Science ®Google Scholar
• Shin MY, Kwun IS. Zinc restored the decreased vascular smooth muscle cell viability under atherosclerotic calcification conditions. Prev Nutr Food Sci. 2014;19(4):363–366. doi:10.3746/pnf.2014.19.4.363
   PubMedGoogle Scholar
• Voelkl J, Tuffaha R, Luong TTD, et al. Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB. J Am Soc Nephrol. 2018;29(6):1636–1648. doi:10.1681/ASN.2017050492
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang X, Zhong X, et al. Puerarin inhibits vascular calcification of uremic rats. Eur J Pharmacol. 2019;855:235–243. doi:10.1016/j.ejphar.2019.05.023
   PubMed Web of Science ®Google Scholar
• Gueiros APS, Gueiros JEB, Nobrega KT, et al. Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study. J Bras Nefrol. 2019;41(3):345–355. doi:10.1590/2175-8239-jbn-2019-0009
   PubMedGoogle Scholar
• Wang P, Quan Z, Luo D, Chen W, Peng D. Spironolactone dose-dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit1. Mol Med Rep. 2019;19(5):3622–3632. doi:10.3892/mmr.2019.10039
   PubMed Web of Science ®Google Scholar
• Agharazii M, St-Louis R, Gautier-Bastien A, et al. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens. 2015;28(6):746–755. doi:10.1093/ajh/hpu225
   PubMed Web of Science ®Google Scholar
• Koike S, Yano S, Tanaka S, Sheikh AM, Nagai A, Sugimoto T. Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification. Int J Mol Scip. 2016;17(5):pii: E1567. doi:10.3390/ijms17091567
   Google Scholar
• Bisson SK, Ung RV, Picard S, et al. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats. J Bone Miner Metab. 2019;37(2):212–223. doi:10.1007/s00774-018-0919-y
   PubMed Web of Science ®Google Scholar